Business Wire

New Medtronic Pacemaker and Defibrillators Treat Heart Rhythm Disorders While Promoting Natural Heart Function

EnRhythm(TM) pacemaker and EnTrust(TM) defibrillators now available in Europe Medtronic, Inc. (NYSE:MDT) today announced the European introductions of the Medtronic EnRhythm(TM) pacemaker ...
FierceBiotech

Medtronic issues EU recall for implantable defibrillators that may not emit strong enough shocks

Medtronic is warning European healthcare providers of a potential safety issue found within many of its implanted heart devices that may make them less effective. As described in a June notice made ...
Becker's Hospital Review

FDA Approves Expanded Use for Medtronic Pacemakers, Defibrillators

The U.S. Food and Drug Administration has approved Minneapolis-based Medtronic’s application to expand the indications for certain pacemakers and defibrillators for patients with heart failure. The ...
Nasdaq

Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins FDA approval of the Medtronic Aurora EV-ICD system includes the system's ...
Healthcare Dive

Abbott, Boston Scientific, Medtronic share data on heart rhythm devices

Medtronic was the only manufacturer of a leadless pacemaker in the U.S. market in the years after it won approval for its Micra device in 2016. While leadless pacemakers were designed to prevent lead- ...
MobiHealthNews

Medtronic launches connected app for pacemaker patients, but patients can't see the data

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...
FierceBiotech

Medtronic Announces FDA Approval of Protecta™ Implantable Defibrillators That Reduce Inappropriate Shocks

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Protecta™ portfolio of implantable cardioverter-defibrillators (ICDs) ...
The American Journal of Managed Care

FDA Approves Medtronic’s Extravascular Defibrillator for Ventricular Arrhythmia

The first-of-its-kind Aurora EV-ICD system offers a single-device, single procedure with a lead placed outside of the heart and veins. The FDA has approved the Aurora Extravascular Implantable ...
Benzinga.com

Medtronic's EV ICD System Proves Effective in Cardiac Arrhythmia Management: Long-term Study Results

Medtronic plc (NYSE:MDT) announced longer-term follow-up results of its investigational Extravascular Implantable Cardioverter Defibrillator (EV ICD) System, designed to treat dangerously fast heart ...
MD&M East

Behind the Design: How Medtronic Found a Goldilocks Solution to Building an EV-ICD

Medtronic's extravascular implantable cardioverter-defibrillator (EV-ICD) may have a mermaid's name, but when the company's R&D team began the project, it was another fictional character that came to ...
Seeking Alpha

Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest

First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins DUBLIN, Oct. 23, 2023 /PRNewswire/ -- Medtronic plc (MDT), a global leader in ...